A detailed history of Raymond James Trust N.A. transactions in Profound Medical Corp. stock. As of the latest transaction made, Raymond James Trust N.A. holds 12,000 shares of PROF stock, worth $90,240. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,000
Previous 10,500 14.29%
Holding current value
$90,240
Previous $88,000 7.95%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$7.47 - $11.18 $11,205 - $16,770
1,500 Added 14.29%
12,000 $95,000
Q2 2024

Jul 25, 2024

BUY
$7.25 - $9.07 $76,125 - $95,235
10,500 New
10,500 $88,000

Others Institutions Holding PROF

About Profound Medical Corp.


  • Ticker PROF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 20,851,300
  • Market Cap $157M
  • Description
  • Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for...
More about PROF
Track This Portfolio

Track Raymond James Trust N.A. Portfolio

Follow Raymond James Trust N.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Trust N.A., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Trust N.A. with notifications on news.